Table 2.

Adverse drug reaction (ADR) frequency related to patient characteristics

Patient characteristic	Patients with ADRs		ADRs		MDADsa	ADRs/MDADsa
	N	%	N	%	N
Gender
Female	2236	80.9	4567	82.9	2130	2.14
Male	500	18.1	886	16.1	1542	0.57
Unknown	29	1.0	53	1.0	n.a.b	n.a.b
Total	2765	100	5506	100.0	3672	1.50
Age group
Neonate (0–27 days)	17	0.6	32	0.6	455c	0.51c
Infant (28 days–23 months)	100	3.6	200	3.6
Child (2–11 years)	141	5.1	234	4.2	1642	0.14
Adolescent (12–18 years)	24	0.9	57	1.0	202	0.28
Adult (19–64 years)	1477	53.4	3062	55.6	981	3.12
Elderly (≥ 65 years)	550	19.9	1086	19.7	393	2.76
Unknown	456	16.5	835	15.2	n.a.b	n.a.b
Total	2765	100	5506	100.0	3672	1.50

MDADs maximum daily administration doses sold

^a× 1 million

^bn.a. not applicable, MDADs and Relative Frequency could not be calculated for unknown gender and age group

^cMDADs and Relative Frequency for age group < 24 months